Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Neoplasm Metastasis 7Brain Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Prostatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Glioblastoma 3Colorectal Neoplasms 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Inflammatory Breast Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma 2Vaginal Neoplasms 1

Interventions

Surgical Procedures, Operative 1Drug Therapy 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Directly Observed Therapy × Surgical Procedures, Operative × Clear all
NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡